Relapse with Nodular Lymphoma Following Combination Chemotherapy for Diffuse Non-Hodgkinʼs Lymphoma
- 1 October 1986
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 9 (5), 420-423
- https://doi.org/10.1097/00000421-198610000-00012
Abstract
Histologic conversion within the non-Hodgkin''s lymphomas is a well-described phenomenon. Conversion from an indolent to that of a more aggressive histologic pattern is the most frequently noted form of this variability. We describe two patients in whom relapse with an indolent nodular lymphoma was noted after combination chemotherapy for diffuse disease. Implications for diagnostic evaluation and therapy as well as the pathogenesis of this unique form of conversion are discussed.This publication has 20 references indexed in Scilit:
- Diffuse Aggressive Lymphomas: Increased Survival After Alternating Flexible Sequences of ProMACE and MOPP ChemotherapyAnnals of Internal Medicine, 1983
- Natural history of malignant lymphomas with divergent histologies at staging evaluationCancer, 1981
- A Multidisciplinary Approach to Non-Hodgkin's LymphomasAnnals of Internal Medicine, 1981
- Histological transformation of non-hodgkin's lymphoma.A prospective studyCancer, 1979
- Non-hodgkin's lymphoma.A study of the evolution of the disease based upon 92 autopsied casesCancer, 1979
- Nodular lymphocytic lymphoma eventuating into diffuse histiocytic lymphoma.Immunoperoxidase demonstration of monoclonalityCancer, 1979
- Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemiaCancer, 1978
- CLL and Diffuse Histiocytic Lymphoma in One Patient: Clonal Proliferation of Two Different B CellsScandinavian Journal of Haematology, 1978
- The coexistence of nodular and diffuse patterns in nodular non-Hodgkin's lymphomas.Significance and clinicopathologic correlationCancer, 1977
- Membrane Markers in “Histiocytic” Lymphomas (Reticulum Cell Sarcomas) 2JNCI Journal of the National Cancer Institute, 1976